Company / Net Income
Decoy Therapeutics Inc. Net Income History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$12.8M
FY2022
5-year range
-$39.5M / -$1.7M
FY2018-FY2022
Trend
-73.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has declined for 3 consecutive years, from -$2M in FY2019 to -$13M in FY2022.
Based on SEC 10-K filings.
-$13M in FY2022.
Declined from -$7M to -$13M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Decoy Therapeutics Inc.'s net income has declined for 3 consecutive years.
- In FY2022, net income decreased 73.7% year-over-year.
- Peak net income was recorded in FY2019.
- Lowest net income in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$12.8M | -73.7% |
| FY2021 | -$7.4M | -6.0% |
| FY2020 | -$6.9M | -315.4% |
| FY2019 | -$1.7M | +95.8% |
| FY2018 | -$39.5M | -35.5% |
| FY2017 | -$29.1M | -263.8% |
| FY2016 | -$8.0M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026